BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9114949)

  • 1. Tap (draft) beer and monoamine oxidase inhibitor dietary restrictions.
    Shulman KI; Tailor SA; Walker SE; Gardner DM
    Can J Psychiatry; 1997 Apr; 42(3):310-2. PubMed ID: 9114949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertensive episode associated with phenelzine and tap beer--a reanalysis of the role of pressor amines in beer.
    Tailor SA; Shulman KI; Walker SE; Moss J; Gardner D
    J Clin Psychopharmacol; 1994 Feb; 14(1):5-14. PubMed ID: 8151003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibitor hypertensive crisis headache and orthostatic hypotension.
    Golwyn DH; Sevlie CP
    J Clin Psychopharmacol; 1993 Feb; 13(1):77-8. PubMed ID: 8486823
    [No Abstract]   [Full Text] [Related]  

  • 4. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The making of a user friendly MAOI diet.
    Gardner DM; Shulman KI; Walker SE; Tailor SA
    J Clin Psychiatry; 1996 Mar; 57(3):99-104. PubMed ID: 8617704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase inhibitor dietary restrictions: what are we asking patients to give up?
    Sweet RA; Brown EJ; Heimberg RG; Ciafre L; Scanga DM; Cornelius JR; Dube S; Forsyth KM; Holt CS
    J Clin Psychiatry; 1995 May; 56(5):196-201. PubMed ID: 7737959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transdermal delivery system of monoamine oxidase inhibitors.
    VanDenBerg CM
    J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase inhibitors: reappraisal of dietary considerations.
    Folks DG
    J Clin Psychopharmacol; 1983 Aug; 3(4):249-52. PubMed ID: 6886038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
    J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of monoamine oxidase inhibitors in primary care.
    Culpepper L
    J Clin Psychiatry; 2012; 73 Suppl 1():37-41. PubMed ID: 22951241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibitors in bipolar endogenous depressives.
    Quitkin FM; McGrath P; Liebowitz MR; Stewart J; Howard A
    J Clin Psychopharmacol; 1981 Mar; 1(2):70-4. PubMed ID: 7028797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching monoamine oxidase inhibitors.
    True BL; Alexander B; Carter B
    Drug Intell Clin Pharm; 1985 Nov; 19(11):825-7. PubMed ID: 4064915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
    Flockhart DA
    J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations.
    Gracious BL; Wisner KL
    Depress Anxiety; 1997; 6(3):124-8. PubMed ID: 9442987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAOIs - does the evidence warrant their resurrection?
    Menkes D; Bosanac P; Castle D
    Australas Psychiatry; 2016 Aug; 24(4):371-3. PubMed ID: 26917855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.